NCT06038903

Brief Summary

Caffeine is a psycho-active substance that is widely consumed in the world. It is seen that its widespread consumption is related to expectancies of consumption as well as cultural factors. Recreationally active individuals may have various expectations from caffeine consumption in line with their lifestyles and goals such as physical, social and/or other aspects. It can be stated that caffeine consumption expectancies have an important role in the process of evaluating consumption patterns. However, in the literature it seems to be very limited information about expectancies related to caffeine consumption. In this direction, the aim of the research was to test the compatibility of Brief-Caffeine Expectancy Questionnaire (B-CaffeQ) to Turkish culture and language. In the study, data will be collected from two separate participant groups and going to analysis. To reveal the structure on the first group (n=250-300 approx.) data, Exploratory Factor Analysis (EFA), and to verify the structure on the second group (n=313) data, Confirmatory Factor Analysis (CFA) will be used. Reliability will be assessed by performing test-retest and internal consistency analyzes on both the two data groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

September 8, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2023

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1 month

First QC Date

September 8, 2023

Last Update Submit

February 16, 2024

Conditions

Keywords

expectationcaffeineBrief-Caffeine Expectancy QuestionnaireLanguage adaptation study

Outcome Measures

Primary Outcomes (1)

  • the Breif-Caffeine Expectancy Questionnaire (B-CaffeQ)

    Brief-Caffeine Expectancy Questionnaire, which is a simplified version of the caffeine expectancy questionnaire developed by Huntley and Juliano (2012), will be included. This questionnaire, whish has been simplified by Kearns et al. (2018) by carrying out validity and reliability studies, has a 7-factor structure, consisting of 20 articles (Huntley \& Juliano, 2012; Kearns et al., 2018). The rating of this questionnaire, which was created in six Likert type, was defined as "1 = Strongly Disagree" to "6= Strongly Agree". In the last part of the questionnaire, there will be questions from which the demographic information of the participants such as age, gender, educational status, etc. obtaine.

    two weeks

Study Arms (2)

EFA group

This group for exploratory factor analysis (EFA)

Other: caffeine consumption expectation

CFA group

This group for confirmatory factor analysis (CFA)

Other: caffeine consumption expectation

Interventions

The group to which the Short-form caffeine expectation questionnaire (B-CaffeQ) was applied, which evaluated the expectations from caffeine consumption.

CFA groupEFA group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Physically active, physiologically healthy and routinely caffeine consumer male and females between 18-60 ages.

You may qualify if:

  • Aged between 18 and 60
  • Physical health individuals

You may not qualify if:

  • Heart disease
  • Using of pacemaker
  • Epilepsy
  • Transient ischemic attack
  • Stroke or similar nervous disorders
  • Psychiatric disease
  • Cardio-pulmonary diseases
  • Pregnancy
  • Drug using that affect the heart rate and blood pressure
  • Systemic, neuroplastic, inflammation disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskişehir Technical University

Eskişehir, Tepebaşı, 26555, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Language

Condition Hierarchy (Ancestors)

CommunicationBehavior

Study Officials

  • celil kaçoğlu, assoc. prof.

    Eskişehir Tecnical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated profesor

Study Record Dates

First Submitted

September 8, 2023

First Posted

September 15, 2023

Study Start

September 8, 2023

Primary Completion

October 10, 2023

Study Completion

October 15, 2023

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations